Lista de obras - Toos Daemen - Dominio Público Uruguay

A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor development

artículo científico publicado en 2015

A systematic analysis on the clinical safety and efficacy of onco-virotherapy

artículo científico publicado en 2021

A virosomal immunization strategy against cervical cancer and pre-malignant cervical disease.

artículo científico publicado en 2006

Alphavirus-based vaccines encoding nonstructural proteins of hepatitis C virus induce robust and protective T-cell responses

artículo científico publicado en 2013

An alphavirus-based therapeutic cancer vaccine: from design to clinical trial

artículo científico publicado en 2018

Antigen-specific active immunotherapy for ovarian cancer

artículo científico publicado en 2014

Antigen-specific active immunotherapy for ovarian cancer

artículo científico publicado en 2010

Antigen-specific active immunotherapy for ovarian cancer

Antigen-specific immunotherapy in ovarian cancer and p53 as tumor antigen

artículo científico publicado en 2012

Antitumor reactivity induced by liposomal MTP-PE in a liver metastasis model of colon cancer in the rat ⬇️

artículo científico publicado el 1 de septiembre de 1995

Augmentation of alphavirus vector-induced human papilloma virus-specific immune and anti-tumour responses by co-expression of interleukin-12.

artículo científico publicado en 2008

CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer.

artículo científico publicado en 2017

Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study.

artículo científico publicado en 2018

Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs

artículo científico publicado en 2002

Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer.

artículo científico publicado en 2009

Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasia

artículo científico publicado en 2006

Epitope Prediction Assays Combined with Validation Assays Strongly Narrows down Putative Cytotoxic T Lymphocyte Epitopes

artículo científico publicado en 2015

Equity in human papilloma virus vaccination uptake?: sexual behaviour, knowledge and demographics in a cross-sectional study in (un)vaccinated girls in the Netherlands

artículo científico publicado en 2014

Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7.

artículo científico publicado en 2003

From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumors

artículo científico publicado en 2011

HLA class I alleles and cervical neoplasia

scientific article published on 01 May 2003

HPV-specific immunotherapy: key role for immunomodulators

artículo científico publicado en 2014

Hepatitis C virus core or NS3/4A protein expression preconditions hepatocytes against oxidative stress and endoplasmic reticulum stress

artículo científico publicado en 2019

Heterologous prime-boost immunizations with a virosomal and an alphavirus replicon vaccine

artículo científico publicado en 2010

Histochemical and electron microscopic characterization of hepatic macrophage subfractions isolated from normal and liposomal muramyl dipeptide treated rats ⬇️

artículo científico publicado el 1 de junio de 1995

Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial

artículo científico publicado en 2009

Immunological and Clinical Effects of Vaccines Targeting p53‐Overexpressing Malignancies ⬇️

artículo científico publicado el 15 de marzo de 2011

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands

artículo científico publicado en 2013

Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-priming

artículo científico publicado en 2004

Influenza virosomes in vaccine development

scientific article published on 01 January 2003

Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activity

artículo científico publicado en 2003

Long-term clinical and immunological effects of p53-SLP® vaccine in patients with ovarian cancer

artículo científico publicado en 2011

Multimodality treatment warranted for ovarian cancer: immunotherapy, a prerequisite to improve prognosis for this vicious disease

artículo científico publicado en 2009

Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy

artículo científico publicado en 2015

On discounting of health gains from human papillomavirus vaccination: effects of different approaches.

artículo científico publicado en 2012

P53-specific T cell responses in patients with malignant and benign ovarian tumors: implications for p53 based immunotherapy

artículo científico publicado en 2007

Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens

artículo científico publicado en 2018

Potential target antigens for a universal vaccine in epithelial ovarian cancer

artículo científico publicado en 2010

Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: a single-arm phase II study

artículo científico publicado en 2012

Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer

artículo científico publicado en 2008

Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapy

artículo científico publicado en 2006

Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines ⬇️

artículo científico publicado el 1 de octubre de 2001

Role of T cell competition in the induction of cytotoxic T lymphocyte activity during viral vector-based immunization regimens

artículo científico publicado en 2010

Role of regulatory T-cells in immunization strategies involving a recombinant alphavirus vector system

artículo científico publicado en 2011

Serum cytokine profiling as a diagnostic and prognostic tool in ovarian cancer: a potential role for interleukin 7

scientific article published on 01 April 2007

Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication

artículo científico publicado en 2015

Superior therapeutic efficacy of alphavirus-mediated immunization against human papilloma virus type 16 antigens in a murine tumour model: effects of the route of immunization.

artículo científico publicado en 2004

Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulation

artículo científico publicado en 2008

Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7.

artículo científico publicado en 2015

The effect of pre-existing immunity on the capacity of influenza virosomes to induce cytotoxic T lymphocyte activity

artículo científico publicado en 2008

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis ⬇️

artículo científico publicado el 31 de mayo de 2011

The virosome concept for influenza vaccines

artículo científico publicado en 2005

Therapeutic immunization and local low-dose tumor irradiation, a reinforcing combination

artículo científico publicado en 2013

Therapeutic vaccination against chronic hepatitis C virus infection

artículo científico

Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer.

artículo científico publicado en 2015

Tumor-infiltrating cytotoxic T lymphocytes as independent prognostic factor in epithelial ovarian cancer with wilms tumor protein 1 overexpression

artículo científico publicado en 2011

Until which age should women be vaccinated against HPV infection? Recommendation based on cost-effectiveness analyses

artículo científico publicado en 2011

Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response.

artículo científico publicado en 2016

Vaccine-based clinical trials in ovarian cancer

artículo científico publicado en 2011

Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity.

artículo científico publicado en 2005

Virosome-mediated delivery of protein antigens to dendritic cells

artículo científico publicado en 2002

Virosomes for antigen and DNA delivery

artículo científico publicado en 2005

Virosomes in vaccine development: induction of cytotoxic T lymphocyte activity with virosome-encapsulated protein antigens

artículo científico publicado en 2002

Lista de obras de Toos Daemen

A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor development

A systematic analysis on the clinical safety and efficacy of onco-virotherapy

A virosomal immunization strategy against cervical cancer and pre-malignant cervical disease.

Alphavirus-based vaccines encoding nonstructural proteins of hepatitis C virus induce robust and protective T-cell responses

An alphavirus-based therapeutic cancer vaccine: from design to clinical trial

Antigen-specific active immunotherapy for ovarian cancer

Antigen-specific active immunotherapy for ovarian cancer

Antigen-specific active immunotherapy for ovarian cancer

Antigen-specific immunotherapy in ovarian cancer and p53 as tumor antigen

Antitumor reactivity induced by liposomal MTP-PE in a liver metastasis model of colon cancer in the rat ⬇️

Augmentation of alphavirus vector-induced human papilloma virus-specific immune and anti-tumour responses by co-expression of interleukin-12.

CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer.

Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study.

Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs

Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer.

Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasia

Epitope Prediction Assays Combined with Validation Assays Strongly Narrows down Putative Cytotoxic T Lymphocyte Epitopes

Equity in human papilloma virus vaccination uptake?: sexual behaviour, knowledge and demographics in a cross-sectional study in (un)vaccinated girls in the Netherlands

Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7.

From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumors

HLA class I alleles and cervical neoplasia

HPV-specific immunotherapy: key role for immunomodulators

Hepatitis C virus core or NS3/4A protein expression preconditions hepatocytes against oxidative stress and endoplasmic reticulum stress

Heterologous prime-boost immunizations with a virosomal and an alphavirus replicon vaccine

Histochemical and electron microscopic characterization of hepatic macrophage subfractions isolated from normal and liposomal muramyl dipeptide treated rats ⬇️

Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial

Immunological and Clinical Effects of Vaccines Targeting p53‐Overexpressing Malignancies ⬇️

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands

Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-priming

Influenza virosomes in vaccine development

Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activity

Long-term clinical and immunological effects of p53-SLP® vaccine in patients with ovarian cancer

Multimodality treatment warranted for ovarian cancer: immunotherapy, a prerequisite to improve prognosis for this vicious disease

Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy

On discounting of health gains from human papillomavirus vaccination: effects of different approaches.

P53-specific T cell responses in patients with malignant and benign ovarian tumors: implications for p53 based immunotherapy

Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens

Potential target antigens for a universal vaccine in epithelial ovarian cancer

Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: a single-arm phase II study

Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer

Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapy

Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines ⬇️

Role of T cell competition in the induction of cytotoxic T lymphocyte activity during viral vector-based immunization regimens

Role of regulatory T-cells in immunization strategies involving a recombinant alphavirus vector system

Serum cytokine profiling as a diagnostic and prognostic tool in ovarian cancer: a potential role for interleukin 7

Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication

Superior therapeutic efficacy of alphavirus-mediated immunization against human papilloma virus type 16 antigens in a murine tumour model: effects of the route of immunization.

Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulation

Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7.

The effect of pre-existing immunity on the capacity of influenza virosomes to induce cytotoxic T lymphocyte activity

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis ⬇️

The virosome concept for influenza vaccines

Therapeutic immunization and local low-dose tumor irradiation, a reinforcing combination

Therapeutic vaccination against chronic hepatitis C virus infection

Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer.

Tumor-infiltrating cytotoxic T lymphocytes as independent prognostic factor in epithelial ovarian cancer with wilms tumor protein 1 overexpression

Until which age should women be vaccinated against HPV infection? Recommendation based on cost-effectiveness analyses

Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response.

Vaccine-based clinical trials in ovarian cancer

Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity.

Virosome-mediated delivery of protein antigens to dendritic cells

Virosomes for antigen and DNA delivery

Virosomes in vaccine development: induction of cytotoxic T lymphocyte activity with virosome-encapsulated protein antigens